131 related articles for article (PubMed ID: 25079654)
1. Anticoagulant-related hospital admissions: serious adverse reactions identified through hospital databases.
Heng C; Rybarczyk-Vigouret MC; Michel B
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):144-51. PubMed ID: 25079654
[TBL] [Abstract][Full Text] [Related]
2. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
[TBL] [Abstract][Full Text] [Related]
3. Positive predictive values of selected hospital discharge diagnoses to identify infections responsible for hospitalization in the French national hospital database.
Sahli L; Lapeyre-Mestre M; Derumeaux H; Moulis G
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):785-9. PubMed ID: 27125251
[TBL] [Abstract][Full Text] [Related]
4. Costs of dengue in three French territories of the Americas: an analysis of the hospital medical information system (PMSI) database.
Uhart M; Blein C; L'Azou M; Thomas L; Durand L
Eur J Health Econ; 2016 May; 17(4):497-503. PubMed ID: 25962729
[TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia: an estimate of the average cost in the hospital setting in France.
Elalamy I; Le Gal G; Nachit-Ouinekh F; Lafuma A; Emery C; Le-Fur C; Chapuis F
Clin Appl Thromb Hemost; 2009; 15(4):428-34. PubMed ID: 18544593
[TBL] [Abstract][Full Text] [Related]
6. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
[TBL] [Abstract][Full Text] [Related]
7. [Use of the PMSI for the detection of adverse drug reactions].
Osmont MN; Cuggia M; Polard E; Riou C; Balusson F; Oger E
Therapie; 2013; 68(4):285-95. PubMed ID: 23981266
[TBL] [Abstract][Full Text] [Related]
8. Inpatient costs of endophthalmitis evaluated for the whole of France.
Colin X; Berdeaux G; Lafuma A; Salvanet-Bouchara A; Kodjikian L
Appl Health Econ Health Policy; 2010; 8(1):53-60. PubMed ID: 20038193
[TBL] [Abstract][Full Text] [Related]
9. [Adverse effects of anticancer drugs: apropos of a pharmacovigilance study at a specialized oncology institution].
Couffignal AL; Lapeyre-Mestre M; Bonhomme C; Bugat R; Montastruc JL
Therapie; 2000; 55(5):635-41. PubMed ID: 11201979
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece.
Alexopoulou A; Dourakis SP; Mantzoukis D; Pitsariotis T; Kandyli A; Deutsch M; Archimandritis AJ
Eur J Intern Med; 2008 Nov; 19(7):505-10. PubMed ID: 19013378
[TBL] [Abstract][Full Text] [Related]
11. In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013.
Maroun R; Maunoury F; Benjamin L; Nachbaur G; Durand-Zaleski I
PLoS One; 2016; 11(9):e0162864. PubMed ID: 27649305
[TBL] [Abstract][Full Text] [Related]
12. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal.
Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351
[TBL] [Abstract][Full Text] [Related]
13. Medication-related adverse events during hospitalization: a retrospective patient record review study in The Netherlands.
Damen NL; Baines R; Wagner C; Langelaan M
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):32-39. PubMed ID: 27193415
[TBL] [Abstract][Full Text] [Related]
14. Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital.
Durrieu G; Batz A; Rousseau V; Bondon-Guitton E; Petiot D; Montastruc JL
Eur J Clin Pharmacol; 2014 Dec; 70(12):1519-26. PubMed ID: 25304009
[TBL] [Abstract][Full Text] [Related]
15. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study.
Leendertse AJ; Van Den Bemt PM; Poolman JB; Stoker LJ; Egberts AC; Postma MJ
Value Health; 2011 Jan; 14(1):34-40. PubMed ID: 21211484
[TBL] [Abstract][Full Text] [Related]
16. Economic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patients.
Knight KK; Wong J; Hauch O; Wygant G; Aguilar D; Ofman JJ
Value Health; 2005; 8(3):191-200. PubMed ID: 15877591
[TBL] [Abstract][Full Text] [Related]
17. [Drug-related anaphylactic shocks: under-reporting and PMSI].
Asfari H; Bousquet C; Trombert Paviot B; Bellet F; Mounier G; Marsille F; Beyens MN; Guy C
Therapie; 2014; 69(6):483-90. PubMed ID: 25269145
[TBL] [Abstract][Full Text] [Related]
18. Management of venous thromboembolism in cancer patients: the economic burden of hospitalizations.
Mahé I; Mayeur D; Krakowski I
Support Care Cancer; 2016 Oct; 24(10):4105-12. PubMed ID: 27146390
[TBL] [Abstract][Full Text] [Related]
19. Impact of prescribing guidelines for inpatient anticoagulation.
Schumock GT; Blackburn JC; Nutescu EA; Walton SM; Finley JM; Lewis RK
Ann Pharmacother; 2004 Oct; 38(10):1570-5. PubMed ID: 15304628
[TBL] [Abstract][Full Text] [Related]
20. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
